Business Wire

Bio-Rad Announces Closing of $1.2 Billion Aggregate Senior Notes Offering

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced today the closing of its ...
Nasdaq

BridgeBio Pharma, Inc. Prices $500 Million Convertible Senior Notes Offering to Lower Debt and Enhance Financial Flexibility

BridgeBio Pharma, Inc. has announced the pricing of $500 million in convertible senior notes at a 1.75% interest rate, maturing in 2031, in a private offering aimed at qualified institutional buyers.
Nasdaq

BridgeBio Pharma Announces $500 Million Convertible Senior Notes Offering to Strengthen Balance Sheet and Enhance Financial Flexibility

BridgeBio Pharma plans to offer $500 million in convertible senior notes, aiming to strengthen its financial position and reduce interest expenses. BridgeBio Pharma, Inc. announced plans to offer $500 ...
Business Wire

Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching

SAN DIEGO--(BUSINESS WIRE)--Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a ...
Business Insider

Bio-Rad Laboratories Inc.DL-Notes 2022(22/32) Bond

The Bio-Rad Laboratories Inc.-Bond has a maturity date of 3/15/2032 and offers a coupon of 3.7000%. The payment of the coupon will take place 2,0 times per biannual on the 15.09.. At the current price ...